Arzu Çoban

573 total citations
27 papers, 378 citations indexed

About

Arzu Çoban is a scholar working on Neurology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Arzu Çoban has authored 27 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 10 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Arzu Çoban's work include Multiple Sclerosis Research Studies (10 papers), Autoimmune Neurological Disorders and Treatments (6 papers) and Peripheral Neuropathies and Disorders (5 papers). Arzu Çoban is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Autoimmune Neurological Disorders and Treatments (6 papers) and Peripheral Neuropathies and Disorders (5 papers). Arzu Çoban collaborates with scholars based in Türkiye, Italy and Greece. Arzu Çoban's co-authors include Erdem Tüzün, Cem İ̇smail Küçükali, Haşmet Hanağası, Merve Çebi, Murat Kürtüncü, Zeliha Matur, Yeşim Parman, Murat Kürtüncü, Erkingül Shugaiv and Mefkûre Eraksoy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the Neurological Sciences and Multiple Sclerosis Journal.

In The Last Decade

Arzu Çoban

24 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arzu Çoban Türkiye 10 165 121 81 49 37 27 378
Lorenzo De Santi Italy 12 79 0.5× 130 1.1× 69 0.9× 34 0.7× 28 0.8× 16 325
Kiyotaka Nakamagoe Japan 13 166 1.0× 119 1.0× 135 1.7× 59 1.2× 32 0.9× 45 525
Teemu Paavilainen Finland 10 105 0.6× 258 2.1× 118 1.5× 54 1.1× 52 1.4× 13 468
Raquel Samões Portugal 12 91 0.6× 117 1.0× 105 1.3× 23 0.5× 24 0.6× 44 363
Dieter Haering Switzerland 5 171 1.0× 304 2.5× 101 1.2× 37 0.8× 47 1.3× 11 459
J.C. Koetsier Netherlands 11 139 0.8× 275 2.3× 136 1.7× 166 3.4× 39 1.1× 21 600
Nadja Siebert Germany 11 216 1.3× 264 2.2× 63 0.8× 33 0.7× 91 2.5× 20 363
Jackie Durfee United States 9 85 0.5× 308 2.5× 57 0.7× 56 1.1× 116 3.1× 12 447
Simon Thebault Canada 10 165 1.0× 285 2.4× 109 1.3× 24 0.5× 37 1.0× 30 478
Iliana Michailidou Netherlands 11 141 0.9× 243 2.0× 170 2.1× 247 5.0× 38 1.0× 21 716

Countries citing papers authored by Arzu Çoban

Since Specialization
Citations

This map shows the geographic impact of Arzu Çoban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arzu Çoban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arzu Çoban more than expected).

Fields of papers citing papers by Arzu Çoban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arzu Çoban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arzu Çoban. The network helps show where Arzu Çoban may publish in the future.

Co-authorship network of co-authors of Arzu Çoban

This figure shows the co-authorship network connecting the top 25 collaborators of Arzu Çoban. A scholar is included among the top collaborators of Arzu Çoban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arzu Çoban. Arzu Çoban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Çoban, Arzu, et al.. (2022). A comprehensive in silico analysis of multiple sclerosis related non-synonymous SNPs and their potential effects on protein structure and function. Multiple Sclerosis and Related Disorders. 68. 104253–104253. 1 indexed citations
3.
Çoban, Arzu, et al.. (2017). Investigation of the prognostic value of adipokines in multiple sclerosis. Multiple Sclerosis and Related Disorders. 15. 11–14. 18 indexed citations
4.
Tüzün, Erdem, et al.. (2015). Increased complexin-1 and decreased miR-185 expression levels in Behçet’s disease with and without neurological involvement. Neurological Sciences. 37(3). 411–416. 11 indexed citations
5.
Çoban, Arzu. (2015). Anti-Neuronal Autoantibodies Associated with Epilepsy and Related Neurological Syndromes. SHILAP Revista de lepidopterología.
6.
Çoban, Arzu, Gülçin Yeğen, Aslı Demirtaş-Tatlıdede, et al.. (2015). NMDA Receptor Encephalitis with Cancer of Unknown Primary Origin. Tumori Journal. 102(2_suppl). S3–S4. 9 indexed citations
7.
Türkoğlu, Recai, Canan Ulusoy, Ece Erdağ, et al.. (2014). Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression. Medical Principles and Practice. 23(3). 239–245. 3 indexed citations
8.
Ulusoy, Canan, Melike Küçükerden, Arzu Çoban, et al.. (2014). Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study. Inflammation Research. 63(10). 799–801. 4 indexed citations
9.
Küçükali, Cem İ̇smail, Murat Kürtüncü, Arzu Çoban, Merve Çebi, & Erdem Tüzün. (2014). Epigenetics of Multiple Sclerosis: An Updated Review. NeuroMolecular Medicine. 17(2). 83–96. 90 indexed citations
10.
Çoban, Arzu, et al.. (2014). Efficiency of Repeated Botulinum Toxin Type-A Injections in Post-Stroke Distal Limb Spasticity. 31(1). 21–27.
11.
Tüzün, Erdem, John S. Tzartos, Esme Ekizoğlu, et al.. (2014). Aquaporin-1 Antibody in Neuromyelitis Optica Patients. European Neurology. 72(5-6). 271–272. 13 indexed citations
12.
Çoban, Arzu, Erkingül Shugaiv, Recai Türkoğlu, et al.. (2014). Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis. International Journal of Neuroscience. 125(5). 352–356. 3 indexed citations
13.
Çoban, Arzu, Erkingül Shugaiv, & Erdem Tüzün. (2013). Beyin Omurilik Sıvısı Lenfositozu ve Geçici Nörolojik Bulguların Eşlik Ettiği Baş Ağrısı Sendromu. Nöro Psikiyatri Arşivi. 50(1). 52–55. 4 indexed citations
14.
Woodhall, Mark, Arzu Çoban, Patrick Waters, et al.. (2013). Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica. Journal of the Neurological Sciences. 335(1-2). 221–223. 30 indexed citations
15.
Çoban, Arzu, Canan Ulusoy, Murat Giriş, et al.. (2013). Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. International Journal of Neuroscience. 123(8). 557–562. 7 indexed citations
16.
Çoban, Arzu, Zeliha Matur, Haşmet Hanağası, & Yeşim Parman. (2010). Iatrogenic Botulism After Botulinum Toxin Type A Injections. Clinical Neuropharmacology. 33(3). 158–160. 42 indexed citations
17.
Çoban, Arzu, Haşmet Hanağası, Saçit Karamürsel, & Orhan Barlas. (2009). Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson's disease. British Journal of Neurosurgery. 23(1). 23–29. 16 indexed citations
18.
Çoban, Arzu, Candan Gürses, Bilge Bılgıç, et al.. (2008). Sporadic Multiple Cerebral Cavernomatosis. The Neurologist. 14(1). 46–49. 9 indexed citations
19.
Çoban, Arzu, Gülşen Akman‐Demir, Halit Özsüt, & Mefkûre Eraksoy. (2007). Multiple Sclerosis–Like Clinical and Magnetic Resonance Imaging Findings in Human Immunodeficiency Virus Positive-Case. The Neurologist. 13(3). 154–157. 8 indexed citations
20.
Çoban, Arzu, et al.. (1981). Breast and other cancer deaths in a mental hospital.. PubMed. 28(3). 371–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026